Antisense Oligonucleotides and RNA Interference - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 369

4. Ambion A. Methods and compositions for tailing and amplifying RNA and

isolating siRNA molecules
B. Methods and kits for sequentially isolating RNA and genomic
DNA from cells
C. System and method for electroporating a sample

1 8

5. Silence Therapeutics A. Interfering RNA molecules

B. Lipids, lipid complexes and use thereof

1 4

6. Calando Therapeutics A. Inhibitors of ribonucleotide reductase subunit 2 and uses thereof 1 2

7. Nucleonics A. dsRNA structures and constructs, and methods for generating and

using the same
B. Conserved Hbv and Hcv sequences useful for gene silencing
C. Methods and constructs for evaluation of RNAi targets and effector
molecules

0 5

8. Roche A. Compositions for delivering nucleic acids to cells

B. Compounds for targeting hepatocytes
C. Methods of treating inflammatory diseases

10 9

9. Alcon A. RNAi-mediated inhibition of ocular targets

B. RNAi-related inhibition of aquaporin and TNF

3 40

10. MDRNA A. Uses of broad spectrum RNAi therapeutics against influenza

B. Compositions and methods for enhancing delivery of nucleic acids
into cells and for modifying expression of target genes in cells
C. Modification of dsRNA molecules

0 3

http:// patft.uspto.gov/netahtml/PTO/search-adv.htm20